These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32666706)

  • 21. [Anti-HMGCR immune-mediated necrotizing myopathy: A case report].
    Zhang YJ; Ma JY; Liu XY; Zheng DF; Zhang YS; Li XG; Fan DS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):558-562. PubMed ID: 37291935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-mediated necrotizing myopathy due to statins exposure.
    Villa L; Lerario A; Calloni S; Peverelli L; Matinato C; DE Liso F; Ceriotti F; Tironi R; Sciacco M; Moggio M; Triulzi F; Cinnante C
    Acta Myol; 2018 Dec; 37(4):257-262. PubMed ID: 30944904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy.
    Landon-Cardinal O; Allenbach Y; Soulages A; Rigolet A; Hervier B; Champtiaux N; Monzani Q; Solé G; Benveniste O
    J Rheumatol; 2019 Jun; 46(6):623-627. PubMed ID: 30554155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (Anti-HMG CoA) Myopathy With Cardiac Involvement: Presentation, Diagnosis, and Management.
    Liu L; Tessier S; Ido F; Longo S; Nanda S
    Cureus; 2022 Mar; 14(3):e23125. PubMed ID: 35425681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review.
    Mekmangkonthong A; Amornvit J; Numkarunarunrote N; Veeravigrom M; Khaosut P
    Pediatr Rheumatol Online J; 2022 Jun; 20(1):40. PubMed ID: 35672822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases].
    Marti J; Kolev I; Lorleac'h A; Besnard S; Pihan M; Marcorelles P
    Rev Med Interne; 2017 Apr; 38(4):228-234. PubMed ID: 27876175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy.
    Kurashige T; Nakamura R; Murao T; Mine N; Sato M; Katsumata R; Kanaya Y; Dodo Y; Sugiura T; Ohshita T
    BMC Immunol; 2024 May; 25(1):30. PubMed ID: 38734636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations.
    Kurashige T; Murao T; Mine N; Sugiura T; Inazuka Y; Kuraoka K; Takahashi T; Maruyama H; Torii T
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):448-457. PubMed ID: 32100014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
    Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A 81-year old man of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with lung adenocarcinoma cancer].
    Yamanaka N; Sato R; Oishi M; Shimizu F; Koga M; Hoshii Y; Kanda T
    Rinsho Shinkeigaku; 2021 Jul; 61(7):456-460. PubMed ID: 34148931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
    Mizuma A; Kouchi M; Netsu S; Yutani S; Kitao R; Suzuki S; Murata K; Nagata E; Takizawa S
    Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
    Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T
    Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series.
    Joseph VMK; Rose EC; Edwards CJ; Lloyd M; Amar SK; Wheeler RD; Forster T; Smith KA; Eren E; Hughes R; Hajela V; Kiely PDW
    Clin Exp Rheumatol; 2022 Feb; 40(2):298-303. PubMed ID: 35200125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
    Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
    Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
    Ge Y; Lu X; Peng Q; Shu X; Wang G
    PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.